Skip to main content

Posts

Computational Arrays and Objects for Scientific and Med Lab Research Featured Post

New diabetes clinical trial: Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3

Published on: 2026-03-12T04:00:00Z Conditions : Cardiovascular-kidney-metabolic Syndrome; Cardiovascular Disease Risk Factor; Kidney Disease; Type 2 Diabetes; Obesity & Overweight Interventions : Drug: GLP-1 receptor agonist; Drug: SGLT2 inhibitor Sponsors : Chung Shan Medical University; National Science and Technology Council, Taiwan Completed https://ift.tt/VNm4XBO

Latest Posts

New diabetes clinical trial: Safety and Effectiveness of Overripe Banana Powder Added to Diabetic Formulas in Type 2 Diabetes

New diabetes clinical trial: Development and Preclinical Validation of DiaBuddy, a Point-of-Care Decision Support Tool for Children With Type 1 Diabetes: A Pilot Clinical Study

New diabetes clinical trial: Prospective Longitudinal Observational Study of Glucose Tolerance Abnormalities Using Continuous Glucose Monitoring for the Identification of Early Loss of Pancreatic Islet Graft Function.

New diabetes clinical trial: Monitoring of the Sympathetic/Vagal Balance Through Multiparametric Analysis of Heart Rate Variability (HRV)

New diabetes clinical trial: Effect of Vitamin D Supplementation on Metabolic Parameters in Patients With Type 2 Diabetes and Vitamin D Deficiency

New diabetes clinical trial: Michigan Weight Navigation Program (MiWeigh) Study

New diabetes clinical trial: Thermographic Camera Validation for Diabetic Foot Assessment (HIK-DM-2026)

New diabetes clinical trial: A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy

New diabetes clinical trial: Effect of Prebiotics in Saudi Adults With Type 2 Diabetes

New diabetes clinical trial: Effect of Cofrogliptin on Beta-Cell Function in LADA Patients